Neurophysiologic Assessment of Neural Tolerance of a New Paramagnetic Complex
The compound coded B-19036, an octadentate chelate of the paramagnetic ion Gd3+ (3, 6 ,9-triaza-12-oxa-3, 6, 9-tricarboxymethylene -10-carboxy-13-phenyl-tridecanoic acid, gadolinium chelate, Fig. 1), is a new contrast agent for magnetic resonance imaging, developed in our laboratories (Felder et al. 1985). Systemic and neural tolerance for B-19036 was evaluated both after intravenous and intrathecal administration.
KeywordsIntrathecal Administration Minimal Effective Dose Gadolinium Chelate Paramagnetic Contrast Agent Paramagnetic Complex
Unable to display preview. Download preview PDF.
- Corsico N, Tirone P (1987) EEG studies in the conscious unrestrained rat: a tool for the study of immediate and delayed neurotoxicity of contrasts media. In: Calabrò A, Leonardi M (eds) Computer Aided Neuroradiology p 255–258Google Scholar
- Felder E et al. (1985) Bracco Industria Chimica EP Patent application n. 230893Google Scholar
- Litchfield Jr J T, Wilcoxon F (1949) A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Therap 96, 99–113Google Scholar